What Can Pharma Do for Patients Post IRA?
Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.
Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform. Hagan notes there is a continuing need to have copay assistance because Medicare patients still face a $2K out of pocket cost, which is still a challenge for many of them.
Visit the PAN Foundation's "Everything You Need to Know About Medicare Reforms" for patients, providers and industry.
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
